Literature DB >> 16445706

Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.

Faruk Oktem1, Fehmi Ozguner, H Ramazan Yilmaz, Efkan Uz, Bumin Dündar.   

Abstract

1. Increased oxidative stress has an important role in the pathogenesis of diabetic nephropathy. The aim of the present study was to evaluate diabetic nephropathy by determining markers of oxidative stress and the urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG), albumin and to investigate the possible protective effects of in vivo melatonin on renal tubular oxidative damage in diabetic rats. 2. Twenty-six rats were randomly divided into three groups: (i) group I, control, non-diabetic rats (n = 9); (ii) group II, untreated diabetic rats (n = 8); and (iii) group III, melatonin-treated diabetic rats (n = 9). In groups II and III, diabetes developed 3 days after administration of a single dose of streptozotocin (35 mg/kg, i.p.). Thereafter, whereas the rats in group II received no treatment, rats in group III began to receive 10 mg/kg per day, i.p., melatonin for 8 weeks. Malondialdehyde (MDA), an index of lipid peroxidation, NAG and microalbumin in the urine, markers of renal tubular damage, were the parameters used for oxidative stress-induced renal injury. Superoxide dismutase (SOD), xanthine oxidase (XO) and glutathione peroxidase (GSH-Px) activities were determined to evaluate changes in the anti-oxidant status of kidney tissue. 3. In untreated diabetic rats, urinary NAG, albumin and renal MDA levels were markedly increased compared with control rats (P < 0.0001). However, these parameters were reduced in diabetic rats by melatonin treatment (P < 0.0001). Urinary excretion of NAG was positively correlated with the microalbuminuria and renal MDA levels (r = 0.8; P < 0.0001). The SOD and XO activities in the untreated diabetic group were found to be significantly higher than those of the control group (P < 0.0001). Superoxide dismutase and XO activities decreased in melatonin-treated rats compared with untreated diabetic rats (P < 0.002 and P < 0.023, respectively). However, the decrease did reach levels seen in control rats. There were no significant differences in GSH-Px activity between the three groups. 4. Therefore, on the basis of these data, we suggest that urinary NAG, albumin excretion, XO activity and MDA levels are more valuable parameters showing the degree of renal tubular injury than classical markers of oxidative stress, including SOD and GSH-Px, in diabetic rat kidneys. Melatonin has an ameliorating effect on oxidative stress-induced renal tubular damage via its anti-oxidant properties. Thus, it may be suggested that urinary NAG excretion and microalbuminuria may be important markers showing the degree of renal changes and the success of long-term treatment of renal impairment with melatonin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16445706     DOI: 10.1111/j.1440-1681.2006.04330.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  10 in total

1.  Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db mice.

Authors:  Hua Zhang; Hong-Mei Zhang; Li-Ping Wu; Dun-Xian Tan; Amrita Kamat; Yun-Qing Li; Michael S Katz; Hanna E Abboud; Russel J Reiter; Bin-Xian Zhang
Journal:  J Pineal Res       Date:  2011-05-27       Impact factor: 13.007

2.  Lisinopril attenuates renal oxidative injury in L-NAME-induced hypertensive rats.

Authors:  Faruk Oktem; Aynur Kirbas; Abdullah Armagan; Ayca Esra Kuybulu; H Ramazan Yilmaz; Fehmi Ozguner; Efkan Uz
Journal:  Mol Cell Biochem       Date:  2011-04-11       Impact factor: 3.396

Review 3.  Renal Protective Effects of Melatonin in Animal Models of Diabetes Mellitus-Related Kidney Damage: A Systematic Review and Meta-Analysis.

Authors:  Qian Luo; Yuzi Cai; Qihan Zhao; Yuhua Jiang; Lei Tian; Yuning Liu; Wei Jing Liu
Journal:  J Diabetes Res       Date:  2022-06-14       Impact factor: 4.061

4.  Reduction of renal superoxide dismutase in progressive diabetic nephropathy.

Authors:  Hiroki Fujita; Hiromi Fujishima; Shinsuke Chida; Keiko Takahashi; Zhonghua Qi; Yukiko Kanetsuna; Matthew D Breyer; Raymond C Harris; Yuichiro Yamada; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

5.  Renoprotective effects of olmesartan medoxomil on diabetic nephropathy in streptozotocin-induced diabetes in rats.

Authors:  Xiaofei Si; Peng Li; Yan Zhang; Yan Zhang; Wei Lv; Dong Qi
Journal:  Biomed Rep       Date:  2013-10-09

Review 6.  Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus.

Authors:  Fareha Wajid; Raju Poolacherla; Fatiha Kabir Mim; Amna Bangash; Ian H Rutkofsky
Journal:  J Diabetes Metab Disord       Date:  2020-07-21

7.  Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice.

Authors:  Ye Zhu; Ze-Liang Li; Ao Ding; Hui Yang; Wei-Ping Zhu; Tong-Xia Cui; Hui-Tao Zhang; Hua Zhang
Journal:  Drug Des Devel Ther       Date:  2019-10-22       Impact factor: 4.162

8.  Sodium Glucose Co-Transporter 2 Inhibitor Ameliorates Autophagic Flux Impairment on Renal Proximal Tubular Cells in Obesity Mice.

Authors:  Kazuhiko Fukushima; Shinji Kitamura; Kenji Tsuji; Yizhen Sang; Jun Wada
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

9.  Oxidative-antioxidative status and hepatic and renal factors following melatonin administration in castrated and intact dogs.

Authors:  Asghar Mogheiseh; Farzaneh Koohi; Saeed Nazifi; Aidin Shojaee Tabrizi; Pegah Taheri; Sina Salavati
Journal:  Basic Clin Androl       Date:  2019-11-15

Review 10.  Mitochondrial Oxidative Stress and Cell Death in Podocytopathies.

Authors:  Yu-Ting Zhu; Cheng Wan; Ji-Hong Lin; Hans-Peter Hammes; Chun Zhang
Journal:  Biomolecules       Date:  2022-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.